Lipton RB, Buse DC, Sandoe CH, Ford JH, et al. Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo-controlled study. Headache 2023 Feb 16. doi: 10.1111/head.14460.
PMID: 36797223